Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach

Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers... (NCCN) has published a set of evidence-based Algorithms were developed based on the National guidelines for genetic testing of hereditary cancers, Comprehensive Cancer Network (NCCN) guidelines including breast, ovarian, and colorectal cancers. for genetic testing for hereditary breast or ovarian This has been changed to: and colorectal cancers. The National Comprehensive Cancer Network This has been changed to: (NCCN) has published a set of evidence-based Algorithms were developed based on the National guidelines for genetic testing of hereditary cancers, Comprehensive Cancer Network (NCCN) guidelines including breast, ovarian, pancreatic, and colorectal for genetic testing for hereditary breast, ovarian, cancers. pancreatic, and colorectal cancers. https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 1 (page number not for citation purposes) XSL FO RenderX JMIR MEDICAL INFORMATICS Shi et al (4) References [6] and [7] have been updated to the following Network, Inc. 2020]. [doi: 10.6004/jnccn.2020.0017] with NCCN's permission and disclaimer statements: [Medline: 32259785] 7. Gupta S, Provenzale D, Llor X, Halverson AL, 6. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Grady W, Chung DC, et al. NCCN guidelines insights: Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, genetic/familial high-risk assessment: breast, ovarian, version 2.2019. J Natl Compr Canc Netw 2019 Sep and pancreatic, version 1.2020. J Natl Compr Canc 01;17(9):1032-1041 [Referenced with permission Netw 2020 Apr;18(4):380-391 [Referenced with from the National Comprehensive Cancer Network, permission from the National Comprehensive Cancer Inc. 2020]. [doi: 10.6004/jnccn.2019.0044] [Medline: 31487681] Textbox 1. Excerpt of National Comprehensive Cancer Network (NCCN) criteria for unaffected individuals’ family history–based genetic testing of breast, ovarian, pancreatic, and colorectal cancers (referenced with permission). Breast or ovarian cancer: 1. First- or second-degree relative with breast cancer at age ≤45 years 2. First- or second-degree relative with ovarian cancer 3. First-degree relative with pancreatic cancer 4. Breast cancer in a male relative 5. Three or more first- or second-degree relatives with breast or prostate cancer on the same side of the family 6. Ashkenazi Jewish and any breast or prostate cancer in any relative at any age 7. BRCA1/2, CHEK2, ATM, PALB2, TP53, PTEN, or CDH1 genes, Cowden Syndrome, Li-Fraumeni Syndrome in any relative at any age Colorectal cancer: 1. MLH1, MSH2, PMS2, MSH6, EPCAM, MYH, or MUTYH genes, Lynch syndrome, familial adenomatous polyposis (FAP), adenomatous polyposis coli (APC), serrated polyposis or polyposis discovered in the coded family history 2. First-degree relative with colon cancer at ≤50 years 3. First-degree relative with endometrial cancer at ≤50 years 4. Three or more first- or second-degree relatives with Lynch syndrome, HNPCC, colon cancer, endometrial, uterine, ovarian, stomach, gastric, small bowel, small intestine, kidney, ureteral, bladder, urethra, brain, pancreas, also all on the same side of the family The correction will appear in the online version of the paper on made after submission to PubMed, PubMed Central, and other the JMIR Publications website on September 13, 2022, together full-text repositories, the corrected article has also been with the publication of this correction notice. Because this was resubmitted to those repositories. References 6. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw 2020 Apr;18(4):380-391 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2020.0017] [Medline: 32259785] 7. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019. J Natl Compr Canc Netw 2019 Sep 01;17(9):1032-1041 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2019.0044] [Medline: 31487681] This is a non–peer-reviewed article. Submitted 07.09.22; accepted 07.09.22; published 13.09.22. Please cite as: Shi J, Morgan KL, Bradshaw RL, Jung SH, Kohlmann W, Kaphingst KA, Kawamoto K, Fiol GD Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach JMIR Med Inform 2022;10(9):e42533 URL: https://medinform.jmir.org/2022/9/e42533 doi: 10.2196/42533 PMID: https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 2 (page number not for citation purposes) XSL FO RenderX JMIR MEDICAL INFORMATICS Shi et al ©Jianlin Shi, Keaton L Morgan, Richard L Bradshaw, Se-Hee Jung, Wendy Kohlmann, Kimberly A Kaphingst, Kensaku Kawamoto, Guilherme Del Fiol. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 13.09.2022. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on https://medinform.jmir.org/, as well as this copyright and license information must be included. https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 3 (page number not for citation purposes) XSL FO RenderX http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JMIR Medical Informatics JMIR Publications

Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach

Loading next page...
 
/lp/jmir-publications/correction-identifying-patients-who-meet-criteria-for-genetic-testing-33dDanknnt

References (2)

  • M. Daly, R. Pilarski, M. Yurgelun, Michael Berry, S. Buys, Patricia Dickson, S. Domchek, Ahmed Elkhanany, S. Friedman, J. Garber, M. Goggins, M. Hutton, S. Khan, C. Klein, W. Kohlmann, A. Kurian, C. Laronga, J. Litton, J. Mak, Carolyn Menendez, S. Merajver, B. Norquist, K. Offit, T. Pal, H. Pederson, Gwen Reiser, K. Shannon, K. Visvanathan, J. Weitzel, M. Wick, K. Wisinski, M. Dwyer, S. Darlow (2020)

    NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

    Journal of the National Comprehensive Cancer Network : JNCCN, 18 4

  • Samir Gupta, D. Provenzale, X. Llor, A. Halverson, W. Grady, D. Chung, S. Haraldsdottir, A. Markowitz, T. Slavin, H. Hampel, R. Ness, J. Weiss, D. Ahnen, Lee-may Chen, G. Cooper, D. Early, F. Giardiello, M. Hall, S. Hamilton, P. Kanth, J. Klapman, A. Lazenby, P. Lynch, R. Mayer, June Mikkelson, S. Peter, S. Regenbogen, M. Dwyer, Ndiya Ogba (2019)

    NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.

    Journal of the National Comprehensive Cancer Network : JNCCN, 17 9

Publisher
JMIR Publications
Copyright
Copyright © The Author(s). Licensed under Creative Commons Attribution cc-by 4.0
ISSN
2291-9694
DOI
10.2196/42533
Publisher site
See Article on Publisher Site

Abstract

(NCCN) has published a set of evidence-based Algorithms were developed based on the National guidelines for genetic testing of hereditary cancers, Comprehensive Cancer Network (NCCN) guidelines including breast, ovarian, and colorectal cancers. for genetic testing for hereditary breast or ovarian This has been changed to: and colorectal cancers. The National Comprehensive Cancer Network This has been changed to: (NCCN) has published a set of evidence-based Algorithms were developed based on the National guidelines for genetic testing of hereditary cancers, Comprehensive Cancer Network (NCCN) guidelines including breast, ovarian, pancreatic, and colorectal for genetic testing for hereditary breast, ovarian, cancers. pancreatic, and colorectal cancers. https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 1 (page number not for citation purposes) XSL FO RenderX JMIR MEDICAL INFORMATICS Shi et al (4) References [6] and [7] have been updated to the following Network, Inc. 2020]. [doi: 10.6004/jnccn.2020.0017] with NCCN's permission and disclaimer statements: [Medline: 32259785] 7. Gupta S, Provenzale D, Llor X, Halverson AL, 6. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Grady W, Chung DC, et al. NCCN guidelines insights: Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, genetic/familial high-risk assessment: breast, ovarian, version 2.2019. J Natl Compr Canc Netw 2019 Sep and pancreatic, version 1.2020. J Natl Compr Canc 01;17(9):1032-1041 [Referenced with permission Netw 2020 Apr;18(4):380-391 [Referenced with from the National Comprehensive Cancer Network, permission from the National Comprehensive Cancer Inc. 2020]. [doi: 10.6004/jnccn.2019.0044] [Medline: 31487681] Textbox 1. Excerpt of National Comprehensive Cancer Network (NCCN) criteria for unaffected individuals’ family history–based genetic testing of breast, ovarian, pancreatic, and colorectal cancers (referenced with permission). Breast or ovarian cancer: 1. First- or second-degree relative with breast cancer at age ≤45 years 2. First- or second-degree relative with ovarian cancer 3. First-degree relative with pancreatic cancer 4. Breast cancer in a male relative 5. Three or more first- or second-degree relatives with breast or prostate cancer on the same side of the family 6. Ashkenazi Jewish and any breast or prostate cancer in any relative at any age 7. BRCA1/2, CHEK2, ATM, PALB2, TP53, PTEN, or CDH1 genes, Cowden Syndrome, Li-Fraumeni Syndrome in any relative at any age Colorectal cancer: 1. MLH1, MSH2, PMS2, MSH6, EPCAM, MYH, or MUTYH genes, Lynch syndrome, familial adenomatous polyposis (FAP), adenomatous polyposis coli (APC), serrated polyposis or polyposis discovered in the coded family history 2. First-degree relative with colon cancer at ≤50 years 3. First-degree relative with endometrial cancer at ≤50 years 4. Three or more first- or second-degree relatives with Lynch syndrome, HNPCC, colon cancer, endometrial, uterine, ovarian, stomach, gastric, small bowel, small intestine, kidney, ureteral, bladder, urethra, brain, pancreas, also all on the same side of the family The correction will appear in the online version of the paper on made after submission to PubMed, PubMed Central, and other the JMIR Publications website on September 13, 2022, together full-text repositories, the corrected article has also been with the publication of this correction notice. Because this was resubmitted to those repositories. References 6. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw 2020 Apr;18(4):380-391 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2020.0017] [Medline: 32259785] 7. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019. J Natl Compr Canc Netw 2019 Sep 01;17(9):1032-1041 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2019.0044] [Medline: 31487681] This is a non–peer-reviewed article. Submitted 07.09.22; accepted 07.09.22; published 13.09.22. Please cite as: Shi J, Morgan KL, Bradshaw RL, Jung SH, Kohlmann W, Kaphingst KA, Kawamoto K, Fiol GD Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach JMIR Med Inform 2022;10(9):e42533 URL: https://medinform.jmir.org/2022/9/e42533 doi: 10.2196/42533 PMID: https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 2 (page number not for citation purposes) XSL FO RenderX JMIR MEDICAL INFORMATICS Shi et al ©Jianlin Shi, Keaton L Morgan, Richard L Bradshaw, Se-Hee Jung, Wendy Kohlmann, Kimberly A Kaphingst, Kensaku Kawamoto, Guilherme Del Fiol. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 13.09.2022. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on https://medinform.jmir.org/, as well as this copyright and license information must be included. https://medinform.jmir.org/2022/9/e42533 JMIR Med Inform 2022 | vol. 10 | iss. 9 | e42533 | p. 3 (page number not for citation purposes) XSL FO RenderX

Journal

JMIR Medical InformaticsJMIR Publications

Published: Sep 13, 2022

There are no references for this article.